Christopher Richard Shea

Prof. Christopher Richard Shea

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JFJohn C. Fox
John C. Fox
JRJon A. Reed
Jon A. Reed
CSChristopher Richard Shea
Christopher Richard Shea
Context .—The diagnosis of recurrent nevus poses a potential challenge to practicing pathologists. Although most recurrent nevi show uniform microscopic findings and pose no great diagnostic difficulty, a few cases exhibit some histopathologic features similar to, and in some cases indistinguishable from, melanoma. Historically, the term pseudomelanoma has been used in the literature to describe such recurrent nevi, although this label has the potential for confusion and is no longer the favored term for recurrent pigmented melanocytic nevi. Objective .—To describe historical, histopathologic, and immunohistochemical features of recurrent pigmented melanocytic nevi and to review briefly the literature surrounding the mechanism of recurrence. Data Sources .—Published peer-reviewed literature and the authors' personal experience. Conclusions .—Recognition of the histopathologic pattern of recurrent nevi leads the pathologist to the correct diagnosis in most cases; however, in particularly challenging specimens or in circumstances in which there is insufficient clinical history, immunohistochemical studies have proved helpful in distinguishing recurrent nevi from melanoma.

6 September 2006 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
WLWenhua Liu
Wenhua Liu
MLMario E. Lacouture
Mario E. Lacouture
JJJesse Jiang
Jesse Jiang
MKMadeleine Kraus
Madeleine Kraus
JDJerome Dickstein
Jerome Dickstein
CSChristopher Richard Shea
Christopher Richard Shea

5 May 2020 in Cells
Verified
Journal Article
Open access
PDF file
PDPiotr Donizy
Piotr Donizy
CWCheng-Lin Wu
Cheng-Lin Wu
JMJason Mull
Jason Mull
MFMasakazu Fujimoto
Masakazu Fujimoto
ACAgata Chłopik
Agata Chłopik
MHMai P Hoang
Mai P Hoang
Introduction: Mucosal melanoma is rare and associated with poorer prognosis in comparison to conventional melanoma subtypes. Little is known about the prognostic significance as well as possible associations between PARP1 and immunologic response in mucosal melanoma. Methods: PARP1, PD-L1 and IDO1 immunostains were performed on 192 mucosal melanomas including 86 vulvar, 89 sinonasal, and 17 anorectal melanomas. Results: By Kaplan–Meier analyses, high PARP1 expression correlated with worse overall and melanoma-specific survival (log-rank p values = 0.026 and 0.047, respectively). Tumors with combined PARP1 and IDO1 high expression correlated with worse overall and melanoma-specific survival (p = 0.015, 0.0034 respectively). By multivariate analyses, high PARP1 expression remained a predictor of worse survival independent of stage. By Fisher’s exact test, high PARP1 expression correlated with highly mitogenic tumors (p = 0.02). High tumoral PD-L1 and IDO1 expression were associated with ulcerated primary tumors (p = 0.019, 0.0019, respectively). By linear regression analyses, correlations between PARP1 expression versus IDO1 expression (p = 0.0001) and mitotic index (p = 0.0052) were observed. Conclusion: Increased expression of PARP1 is an independent negative prognostic marker in mucosal melanomas. The association between PARP1 and IDO1 and their combined adverse prognostic role raise the potential of combined therapy in mucosal melanoma.

1 November 2012 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Open access
XZXuefeng Zhang
Xuefeng Zhang
EHElizabeth Hyjek
Elizabeth Hyjek
KSKeyoumars Soltani
Keyoumars Soltani
VPVesna Petronic-Rosic
Vesna Petronic-Rosic
CSChristopher R. Shea
Christopher R. Shea
Context.—Pemphigus is a group of autoimmune vesiculobullous diseases characterized by immunoglobulin G (IgG) antibodies directed against desmosomal adhesion proteins, with IgG4 being the predominant subclass in active diseases. Direct immunofluorescence for IgG performed on fresh-frozen tissue plays a crucial role in diagnosing pemphigus. However, the diagnosis might be hindered when frozen tissue is not available. Objective.—To evaluate the usefulness of immunohistochemistry for IgG4 performed on paraffin sections as a diagnostic test for pemphigus. Design.—Eighteen immunofluorescence-proven pemphigus cases (12 pemphigus vulgaris, 6 pemphigus foliaceus) were studied. Four normal skin specimens and 32 nonpemphigus vesiculobullous disease specimens served as controls. Paraffin sections of all cases were examined immunohistochemically for IgG4 expression. Positivity was defined as distinct, condensed, continuous immunoreactivity localized to the intercellular junctions of keratinocytes. Results.—The immunostains were independently evaluated in a masked manner by 3 pathologists, with a 100% interobserver agreement. Nine of 12 pemphigus vulgaris cases (sensitivity 75.0%), and 4 of 6 pemphigus foliaceus cases (sensitivity 66.7%), were positive for IgG4 immunostain. The overall sensitivity was 72.2%. One control specimen (bullous pemphigoid) showed IgG4 positivity (specificity 97.2%). In specimens demonstrating acantholysis, 8 of 10 pemphigus vulgaris cases (sensitivity 80.0%) and 4 of 4 pemphigus foliaceus cases (sensitivity 100.0%) were positive for IgG4. The overall sensitivity for specimens with acantholytic lesions was 85.7%. Conclusion.—Immunohistochemistry for IgG4 provides a reasonably sensitive and highly specific test for diagnosing pemphigus, especially when frozen tissue is not available, and active acantholytic lesions are examined.

18 October 2006 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
DZDaniel C. Zedek
Daniel C. Zedek
BMBettina A. Murphy
Bettina A. Murphy
CSChristopher R. Shea
Christopher R. Shea
MHMichael G. Hitchcock
Michael G. Hitchcock
JRJason C. Reutter
Jason C. Reutter
WWWain L. White
Wain L. White

1 July 2011 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
VPVictor G Prieto
Victor G Prieto
CSChristopher Richard Shea
Christopher Richard Shea
Histologic analysis allows accurate classification of most melanocytic lesions as benign or malignant. Only in a minority of lesions is it necessary to use other techniques as an aid in the diagnosis. Among them, most authors recommend immunohistochemistry. To describe how to apply immunohistochemistry to particular differential diagnoses and the potential pitfalls. Personal experience and review of literature. There is no single marker, or combination thereof, that establishes an unequivocal diagnosis of melanoma or nevus. Thus it is necessary to carefully analyze the pattern of expression (patchy versus diffuse) and localization (maturation) in the context of morphologic standard features.